Navigation Links
New type of vaccines deliver stronger and faster immune response
Date:11/24/2008

ances the response of the associated attack cells (producing large numbers of CD8+ cells) and is an important reason why the platform is able to deliver such a strong immune response.
  • InVacc provides rapid protection. In animal tests, complete protection was achieved in less than 3 days after a single vaccination. This could have significant implications for the handling of epidemics, quickly halting infection rates and preventing major outbreaks.

    • The Scandinavian company Novo A/S and the Novo Nordisk Foundation have such faith in the new technology that they have already invested funds to create a strategic plan for development and use of the platform. "The grants awarded through our Novo Seeds programme are only for very select projects that show outstanding promise, both scientifically and commercially, explains Novo Seeds Investment Director, Stephen Christgau." "The InVacc platform is definitely one of those. Our grants will help the team to develop and commercialise their groundbreaking research and validate the advantages of the vaccine platform against competing technologies".

    Peter Holst, PhD, from the research team, (together with the Technical Transfer Unit at the University of Copenhagen), are currently also seeking backing from international funds to take the project to its next phase of development and ultimately into clinical trials.


    '/>"/>

    Contact: sandra szivos
    sasz@sund.ku.dk
    0045-353-6921
    University of Copenhagen
    Source:Eurekalert

    0

    GOOD

    Page: 1 2

    Related biology news :

    1. Syracuse University partners with Serum Institute of India to develop vaccines for children
    2. Prostate cancer vaccines more effective with hormone therapy
    3. From foe to friend: Researchers use salmonella as a way to administer vaccines in the body
    4. VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
    5. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
    6. Depression during pregnancy can double risk of preterm delivery
    7. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
    8. RNA molecules, delivery system improve vaccine responses, effectiveness
    9. Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency
    10. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
    11. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/2/2009)PHILADELPHIA People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smo
    (Date:12/2/2009)PHILADELPHIA Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researc
    (Date:12/2/2009)Researchers from the University of Georgia College of Veterinary Medicine have made an "unexpected" dual discovery that could open new avenues for treating Ichthyophthirius multifiliis, or "Ich", a de
    Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3E Cigarettes Pose a Health Hazard FDA Warns 52474 1E Cigarettes Pose a Health Hazard FDA Warns 52474 2E Cigarettes Pose a Health Hazard FDA Warns 52474 3FDA Acts to Protect Public Health from Electronic Cigarettes 52470 1FDA Acts to Protect Public Health from Electronic Cigarettes 52470 2FDA Acts to Protect Public Health from Electronic Cigarettes 52470 3Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 1Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 2Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 3
    ...Ariz. Sept. 15, 2008 Investigators at the Transl...nnounced a link between the brain protein KIBRA an... to promising new treatments for this memory-robbi...ious TGen-led study published in the prestigious j...n KIBRA and memory in healthy adults. , In the ne...
    ...ections indicating that more than 50% of all osteo...ar 2050, the prevention and treatment of osteoporo... the region. , The IOF World Congress on Osteopor...sia, is an ideal opportunity for health profession...gress devoted to all aspects of osteoporosis and r...
    ...searchers have found that a gene variant known to ...ldren plays a similar role in white American child... most common chronic illness among children in the...hich a variety of genes are thought to interact wi... produce its effects. As in many other genetic dis...
    Other Biology News:International TGen-led team finds link between brain protein and Alzheimer's disease 2International TGen-led team finds link between brain protein and Alzheimer's disease 3International TGen-led team finds link between brain protein and Alzheimer's disease 4IOF World Congress on Osteoporosis in Bangkok to address Asian issues 2More findings on gene involved in childhood asthma 2
    (Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
    (Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
    (Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
    (Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
    Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
    ...v. 7 InterMune, Inc.,(Nasdaq: ITMN ) today annou...ve Officer and President of InterMune, will presen... November 11, 2008 at 4:00 p.m. EST., To access a... and other,interested parties may log on to the in...site at http://www.intermune.com . The company re...
    ... 7 Human Genome Sciences,Inc. (Nasdaq: HGSI ) an...e,Bank Biotech Boston Confab will be webcast and m... http://www.newscom.com/cgi-bin/prnh/20080416/HGSL... management team will present,a corporate overview...Time., Investors interested in listening to the l...
    ...ov. 7 Cepheid (Nasdaq:,CPHD) today announced that...investor conferences, and invited investors to par...Health Care Conference, Phoenix, AZ Friday, N...Piper Jaffray Health Care Conference, New York, NY...rn Time Accessing Webcasts, To access the live w...
    Other Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2
    Peptides from Thermo Scientific
    ... Shakers combine high durability and capacity with...e. The patented triple-counterbalanced heavy-duty ... run at high speed with heavy, out-of-balance load...elivered with tight uniformity by twin blowers and...
    ... technology platform that automates gel processing...ity sample preparation can be carried out by an un...gy platform that automates gel processing for high...ctions of high-resolution gel imaging, precision s...
    CQCS kit for first KR 4i from Thermo Scientific
    Biology Products: